Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor binding

被引:9
作者
Gaffney, D
Pullinger, CR
O'Reilly, DS
Hoffs, MS
Cameron, I
Vass, JK
Kulkarni, MV
Kane, JP
Schumaker, VN
Watts, GF
Packard, CJ
机构
[1] N Glasgow Hosp Univ, Glasgow Royal Infirm, Dept Pathol Biochem, NHS Trust, Glasgow G31 2ER, Lanark, Scotland
[2] Beatson Inst Canc Res, Glasgow, Lanark, Scotland
[3] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA USA
[4] Univ Western Australia, Royal Perth Hosp, Dept Med, Perth, WA 6009, Australia
[5] Univ Western Australia, Royal Perth Hosp, Western Australian Heart Res Inst, Perth, WA 6009, Australia
关键词
apolipoproteins B; LDL cholesterol; genetics; biological assay; mutation detection;
D O I
10.1016/S0009-8981(02)00106-7
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Three mutations in the apolipoprotein B (apoB) gene have previously been established as important causes of impaired receptor binding of LDL and, hence, Familial Defective Apolipoprotein B 100 (FDB). Previously, undescribed mutations were sought. Methods: Using denaturing gradient gel electrophoresis for mutation detection, DNA from 1852 new patients was examined. Results: A previously undiscovered mutation was found in codon 35 16, located between known FDB mutations at codons 3500 and 3531. The new mutation introduces a positively charged amino acid-lysine-while other FDB mutations remove a positively charged residue, arginine. The phenotype was intriguing, LDL derived from N3516K heterozygotes allowed only poor growth of an LDL cholesterol-dependent cell line. ApoB-100-specific antibody MB47 bound to LDL from N3516K heterozygotes with increased affinity indicating a probable conformational change caused by the substitution. In contrast to these results, a competitive displacement assay in fibroblasts showed normal (or better) binding affinity to LDL receptors and using dynamic laser scattering no preferential accumulation of 3516K LDL particles in plasma was found. Conclusion: Discovery of the mutation and characterisation of N3516K LDL reveals another naturally occurring apoB mutation that influences conformation of LDL apoB and its interaction with the LDL receptor, (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 34 条
[1]   Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100 [J].
Borén, J ;
Lee, I ;
Zhu, WM ;
Arnold, K ;
Taylor, S ;
Innerarity, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1084-1093
[2]  
CHATTERTON JE, 1995, J LIPID RES, V36, P2027
[3]   IDENTIFICATION OF APOLIPOPROTEIN B100 POLYMORPHISMS THAT AFFECT LOW-DENSITY-LIPOPROTEIN METABOLISM - DESCRIPTION OF A NEW APPROACH INVOLVING MONOCLONAL-ANTIBODIES AND DYNAMIC LIGHT-SCATTERING [J].
CHATTERTON, JE ;
SCHLAPFER, P ;
BUTLER, E ;
GUTIERREZ, MM ;
PUPPIONE, DL ;
PULLINGER, CR ;
KANE, JP ;
CURTISS, LK ;
SCHUMAKER, VN .
BIOCHEMISTRY, 1995, 34 (29) :9571-9580
[4]  
Choong ML, 1997, CLIN CHEM, V43, P916
[5]  
*DHEW, 1975, DHEW PUBL
[6]  
EGUSA G, 1983, J LIPID RES, V24, P1261
[7]  
Fisher E, 1999, CLIN CHEM, V45, P1026
[8]  
FROSTEGARD J, 1990, J LIPID RES, V31, P37
[9]   INDEPENDENT MUTATIONS AT CODON-3500 OF THE APOLIPOPROTEIN-B GENE ARE ASSOCIATED WITH HYPERLIPIDEMIA [J].
GAFFNEY, D ;
REID, JM ;
CAMERON, IM ;
VASS, K ;
CASLAKE, MJ ;
SHEPHERD, J ;
PACKARD, CJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) :1025-1029
[10]  
Gaffney D, 1998, NEW ENGL J MED, V339, P1640